Double heterozygous pathogenic variants in the BRCA1 and BRCA2 genes in a patient with bilateral metachronous breast cancer

被引:2
作者
Mampel, Alejandra [1 ,2 ]
Sottile, Mayra L. [3 ,4 ]
Denita-Juarez, Silvina P. [5 ]
Vargas, Ana L. [1 ,2 ]
Vargas-Roig, Laura M. [2 ,3 ]
机构
[1] Univ Hosp, Mendoza, Argentina
[2] Natl Univ Cuyo, Med Sch, Mendoza, Argentina
[3] Natl Univ Cuyo, Natl Res Council Argentine, Tumor Biol Lab, Inst Med & Expt Biol Cuyo, Mendoza, Argentina
[4] Univ Mendoza, Med Sch, Mendoza, Argentina
[5] HEMA, Mendoza, Argentina
关键词
BRCA1; BRCA2; Breast cancer; Double heterozygote; OVARIAN-CANCER; MUTATIONS; RISK; FAMILIES;
D O I
10.1016/j.cancergen.2021.11.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Double heterozygosity pathogenic variants in BRCA1 and BRCA2 genes are a very rare finding, particularly in non-Ashkenazi individuals. We described the first case of double heterozygosity variants in a non Ashkenazi Argentinean woman with metachronous bilateral breast cancer. The proband is a 65-year-old female diagnosed with invasive ductal carcinoma in the left breast at 45 years old and invasive carcinoma in the right breast at 65 years old. She underwent a multi-gene panel testing indicating the presence of two concurrent heterozygous germline deleterious variants NM_0 0730 0.4(BRCA1):c.4201C > T (p.Gln1401Ter), and NM_0 0 0 059.3(BRCA2):c.5146_5149del (p.Tyr1716fs). . The patient's son (40 years-old) was found to have the inherited pathogenic variant in BRCA2 gene. There are few reports of double heterozygosity variants in BRCA1 and BRCA2 genes in Latin America. The two pathogenic variants identified in our patient have not been described together so far. (c) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:14 / 17
页数:4
相关论文
共 23 条
[1]   Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review [J].
Andres Ossa, Carlos ;
Torres, Diana .
ONCOLOGIST, 2016, 21 (07) :832-839
[2]   Breast and ovarian cancer risk evaluation in families with a disease-causing mutation in BRCA1/2 [J].
Beristain E. ;
Ibáñez B. ;
Vergara I. ;
Martínez-Bouzas C. ;
Guerra I. ;
Tejada M.I. .
Journal of Community Genetics, 2010, 1 (2) :91-99
[3]   BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population [J].
Cardoso, Florencia C. ;
Goncalves, Susana ;
Mele, Pablo G. ;
Liria, Natalia C. ;
Sganga, Leonardo ;
Diaz Perez, Ignacio ;
Podesta, Ernesto J. ;
Solano, Angela R. .
HUMAN GENOMICS, 2018, 12
[4]   Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021 [J].
Daly, Mary B. ;
Pal, Tuya ;
Berry, Michael P. ;
Buys, Saundra S. ;
Dickson, Patricia ;
Domchek, Susan M. ;
Elkhanany, Ahmed ;
Friedman, Susan ;
Goggins, Michael ;
Hutton, Mollie L. ;
Karlan, Beth Y. ;
Khan, Seema ;
Klein, Catherine ;
Kohlmann, Wendy ;
Kurian, Allison W. ;
Laronga, Christine ;
Litton, Jennifer K. ;
Mak, Julie S. ;
Menendez, Carolyn S. ;
Merajver, Sofia D. ;
Norquist, Barbara S. ;
Offit, Kenneth ;
Pederson, Holly J. ;
Reiser, Gwen ;
Senter-Jamieson, Leigha ;
Shannon, Kristen Mahoney ;
Shatsky, Rebecca ;
Visvanathan, Kala ;
Weitzel, Jeffrey N. ;
Wick, Myra J. ;
Wisinski, Kari B. ;
Yurgelun, Matthew B. ;
Darlow, Susan D. ;
Dwyer, Mary A. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (01) :77-102
[5]   The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective [J].
Dutil, Julie ;
Golubeva, Volha A. ;
Pacheco-Torres, Alba L. ;
Diaz-Zabala, Hector J. ;
Matta, Jaime L. ;
Monteiro, Alvaro N. .
BREAST CANCER RESEARCH AND TREATMENT, 2015, 154 (03) :441-453
[6]   Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations [J].
Gallardo, M ;
Silva, A ;
Rubio, L ;
Alvarez, C ;
Torrealba, C ;
Salinas, M ;
Tapia, T ;
Faundez, P ;
Palma, L ;
Riccio, M ;
Paredes, H ;
Rodriguez, M ;
Cruz, A ;
Rousseau, C ;
King, M ;
Camus, M ;
Alvarez, M ;
Carvallo, P .
BREAST CANCER RESEARCH AND TREATMENT, 2006, 95 (01) :81-87
[7]   Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families [J].
Gonzalez-Hormazabal, Patricio ;
Gutierrez-Enriquez, Sara ;
Gaete, Daniel ;
Reyes, Jose M. ;
Peralta, Octavio ;
Waugh, Enrique ;
Gomez, Fernando ;
Margarit, Sonia ;
Bravo, Teresa ;
Blanco, Rafael ;
Diez, Orland ;
Jara, Lilian .
BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (03) :705-716
[8]   Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management [J].
Heidemann, Simone ;
Fischer, Christine ;
Engel, Christoph ;
Fischer, Barbara ;
Harder, Lana ;
Schlegelberger, Brigitte ;
Niederacher, Dieter ;
Goecke, Timm O. ;
Doelken, Sandra C. ;
Dikow, Nicola ;
Jonat, Walter ;
Morlot, Susanne ;
Schmutzler, Rita C. ;
Arnold, Norbert K. .
BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (03) :1229-1239
[9]   Founder BRCA1/2 mutations in the Europe: Implications for hereditary breast-ovarian cancer prevention and control [J].
Janavičius R. .
EPMA Journal, 2010, 1 (3) :397-412
[10]   Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations [J].
Jara, Lilian ;
Morales, Sebastian ;
de Mayo, Tomas ;
Gonzalez-Hormazabal, Patricio ;
Carrasco, Valentina ;
Godoy, Raul .
BIOLOGICAL RESEARCH, 2017, 50